Ruken Esra Demirdogen
Unsustainable styles of production and consumption
caused many different diseases rise. This put huge burden
on healthcare systems. Among these diseases cancer with
increasing incidence and prevalence is a severe social, economic
and health challenge. The current treatment strategies
relying on chemotherapy has limited success due to
poor bioavailability, high-dose requirements, adverse side
effects, low therapeutic indices, multiple drug resistance,
and non-specific targeting of the drugs used. As a solution
to all “theranostics” -the precision medicine providing
simultaneous diagnosis and targeted treatment- rose.
The key actor -the drug- can become more effective by
increasing the biodistribution, selectivity, safety-efficacy
ratio via supramolecular nanomedicines
